Welcome to the CCO Site

Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education. 

Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.

Submit

The IAS COVID-19 Conference: Prevention – Rapid Recap

February 2, 2021; Virtual
Hear insights from Jens D. Lundgren, MD, DMSc, on some of the most important COVID-19 prevention data reported at the 2021 IAS COVID-19 Conference: Prevention, including new findings on potential SARS-CoV-2 suppressive therapies, strategies for vaccination and mass testing, and interventions to prevent transmission of COVID-19 while maintaining desired outcomes in HIV care.
Jens D. Lundgren, MD, DMSc
Released: February 17, 2021

In this episode, Dr. Jens Lundgren discusses results from key studies reported at the IAS COVID-19 Conference: Prevention, including new findings on potential SARS-CoV-2 suppressive therapies, strategies for vaccination and mass testing, and interventions to prevent transmission of COVID-19 while maintaining desired outcomes in HIV care.

Jens D. Lundgren, MD, DMSc
Professor
Rigshospitalet, University of Copenhagen
Copenhagen, Denmark
Director
Centre of Excellence for Health, Immunity and Infection (CHIP)
Rigshospitalet, University of Copenhagen
Copenhagen, Denmark

Acknowledgements

Provided by Clinical Care Options, LLC

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA

Sophia Kelley
(203)-316-2125
skelley@clinicaloptions.com
www.clinicaloptions.com

Produced in collaboration with
Educational grant provided by:
Merck Sharp & Dohme Corp.
Regeneron Pharmaceuticals, Inc.

Related Content

Clinical Care Options (CCO) podcast with Dr William Short on current guidelines and clinical trial data informing optimal selection of first-line antiretroviral therapy for HIV

William R. Short, MD, MPH, AAHIVS Released: May 7, 2021

Clinical Care Options (CCO) presents Howard Grossman, MD, and Cristina Mussini, MD, answering questions on HIV prevention in older individuals

Howard Grossman, MD Cristina Mussini, MD Released: May 6, 2021

Clinical Care Options (CCO) expert Dr. Yasuhito Tanaka on HCC risk prediction in patients with chronic hepatitis B using the novel serum biomarker HBcrAg

person default Yasuhito Tanaka, MD, PhD Released: May 6, 2021

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue